Elimination of quinolone antibiotic carryover through use of antibiotic-removal beads.
about
Pharmacodynamics of gatifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model: impact of area under the curve/MIC ratios on eradication.Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic model.Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolonesPharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similarFluoroquinolone resistance in Bacteroides fragilis following sparfloxacin exposureComparison of once-daily versus twice-daily administration of cefdinir against typical bacterial respiratory tract pathogens.Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents.Pharmacodynamics of trovafloxacin and levofloxacin against Bacteroides fragilis in an in vitro pharmacodynamic model.Comparative pharmacodynamics of three newer fluoroquinolones versus six strains of staphylococci in an in vitro model under aerobic and anaerobic conditions.Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model.Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacinLevofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa.
P2860
Q34104410-17C1B870-A780-41F4-B5A5-D249BF2BA7DEQ35013754-43741BD6-06BB-475F-858A-4C8C2441707FQ35111853-F27D9BAA-50B5-47C8-8259-4DD00D02EE09Q35822946-177B48C0-E151-43C3-B6F6-12F6AA156005Q39471750-D6F8B9DE-3687-4540-8B1E-88DB54CA18DDQ39478644-A994E6AA-21A7-44AE-AC69-353484CEDBADQ39506766-94194947-41D4-456B-A1A5-9E00AEF22AF7Q39650985-4E660CAC-CC74-4F98-AA14-7A3D81410EE2Q39651777-04AB15DF-36D5-4E4F-8871-E95F8A77A6ECQ39781591-507AF2FE-44C3-487B-A820-A38F7141820DQ42078632-8951A1E5-DC71-4D64-B563-AC6D7D3089F9Q45265795-84E8F954-8DCE-4C5A-A2F1-DD27D11D3969
P2860
Elimination of quinolone antibiotic carryover through use of antibiotic-removal beads.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Elimination of quinolone antibiotic carryover through use of antibiotic-removal beads.
@ast
Elimination of quinolone antibiotic carryover through use of antibiotic-removal beads.
@en
type
label
Elimination of quinolone antibiotic carryover through use of antibiotic-removal beads.
@ast
Elimination of quinolone antibiotic carryover through use of antibiotic-removal beads.
@en
prefLabel
Elimination of quinolone antibiotic carryover through use of antibiotic-removal beads.
@ast
Elimination of quinolone antibiotic carryover through use of antibiotic-removal beads.
@en
P2093
P2860
P356
P1476
Elimination of quinolone antibiotic carryover through use of antibiotic-removal beads.
@en
P2093
Gilliland SS
Larsson AJ
Rotschafer JC
Zabinski RA
P2860
P304
P356
10.1128/AAC.37.6.1377
P407
P577
1993-06-01T00:00:00Z